Patient Research Cohort: Rapidly Evolving Multiple Sclerosis

Summary

Patient Research Cohort: Rapidly Evolving Multiple Sclerosis is a clinical trial^[1].

Key Facts

• Patient Research Cohort: Rapidly Evolving Multiple Sclerosis is in the country of Rapidly Evolving Multiple Sclerosis — country (P17): United Kingdom^[2].
• Patient Research Cohort: Rapidly Evolving Multiple Sclerosis's instance of is recorded as Rapidly Evolving Multiple Sclerosis — instance of (P31): clinical trial^[3].
• Patient Research Cohort: Rapidly Evolving Multiple Sclerosis's start time is recorded as +2010-01-31T00:00:00Z^[4].
• Patient Research Cohort: Rapidly Evolving Multiple Sclerosis's end time is recorded as +2012-11-30T00:00:00Z^[5].
• Patient Research Cohort: Rapidly Evolving Multiple Sclerosis's contributor to the creative work or subject is recorded as Rapidly Evolving Multiple Sclerosis — contributor to the creative work or subject (P767): Queen Mary University of London^[6].
• Patient Research Cohort: Rapidly Evolving Multiple Sclerosis's contributor to the creative work or subject is recorded as Rapidly Evolving Multiple Sclerosis — contributor to the creative work or subject (P767): GSK^[7].
• Patient Research Cohort: Rapidly Evolving Multiple Sclerosis's sponsor is recorded as Rapidly Evolving Multiple Sclerosis — sponsor (P859): Imperial College London^[8].
• Patient Research Cohort: Rapidly Evolving Multiple Sclerosis's main subject is recorded as Rapidly Evolving Multiple Sclerosis — main subject (P921): multiple sclerosis^[9].
• Patient Research Cohort: Rapidly Evolving Multiple Sclerosis's main subject is recorded as Rapidly Evolving Multiple Sclerosis — main subject (P921): sclerosis^[10].
• Patient Research Cohort: Rapidly Evolving Multiple Sclerosis's number of participants is recorded as {'unit': '1', 'amount': '+200'}^[11].
• Patient Research Cohort: Rapidly Evolving Multiple Sclerosis's title is recorded as Patient Research Cohort: Rapidly Evolving Multiple Sclerosis Opening the Window of Therapeutic Opportunity^[12].
• Patient Research Cohort: Rapidly Evolving Multiple Sclerosis's short name is recorded as PRC-REMS^[13].
• Patient Research Cohort: Rapidly Evolving Multiple Sclerosis's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[14].
• Patient Research Cohort: Rapidly Evolving Multiple Sclerosis's ClinicalTrials.gov ID is recorded as NCT01044576^[15].
• Patient Research Cohort: Rapidly Evolving Multiple Sclerosis's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}^[16].
• Patient Research Cohort: Rapidly Evolving Multiple Sclerosis's research site is recorded as Rapidly Evolving Multiple Sclerosis — research site (P6153): Imperial College London Diabetes Centre^[17].
• Patient Research Cohort: Rapidly Evolving Multiple Sclerosis's study type is recorded as Rapidly Evolving Multiple Sclerosis — study type (P8363): observational study^[18].